Why Mucus Overproduction Occurs and How to Manage It

Gain insight into why a vital bodily process can become problematic. Discover the causes and practical management for relief.

Mucus overproduction happens when the body’s normal defense system goes into overdrive, usually triggered by infection, inflammation, allergens, or chronic disease. Your airways, sinuses, and gut are lined with cells whose entire job is to secrete mucus, and dozens of signals from the immune system, the nervous system, and the environment can push those cells to produce far more than needed. The result ranges from a temporarily stuffy nose to life-threatening airway plugging in diseases like severe asthma or cystic fibrosis. Understanding what flips the switch helps explain why certain treatments work and others are a waste of time.

What Mucus Is Supposed to Do

Mucus is a gel made mostly of water, salts, and large sugar-coated proteins called mucins. In the airways, two mucins do most of the heavy lifting: MUC5AC and MUC5B. Together they form the sticky mesh that lines your nose, throat, and lungs, trapping inhaled particles, bacteria, and viruses so that tiny hair-like structures called cilia can sweep the whole mess toward your throat to be swallowed or coughed out. Under healthy conditions, mucus production and clearance are in balance. You swallow roughly a liter of nasal and airway mucus every day without noticing. Problems start when production outpaces clearance, or when the mucus itself becomes too thick and sticky to move.

How Cells Ramp Up Production

Two main cell types produce airway mucus: goblet cells scattered across the airway surface and submucosal glands buried deeper in the airway wall. In chronic disease, both can multiply and enlarge. Goblet cell hyperplasia, where the number of mucus-secreting goblet cells increases dramatically, is a hallmark of COPD airways, though the full set of signals driving it is still being worked out. The submucosal glands can also swell to several times their normal size. In animal models of chronic airway disease, gland area grew roughly threefold within two months, and the proportion of mucus-producing cells within those glands roughly tripled as well.

Irritant exposure accelerates the process. When airways are already sensitized by allergens, adding an irritant like tobacco smoke further increases the goblet cell and submucosal gland populations, worsening mucus production, airway resistance, and the risk of mucus plugging. This is one reason smokers with allergies or asthma tend to have far worse mucus problems than either condition alone would predict.

The Signaling Cascade Behind Excess Mucin

At the molecular level, several immune and growth signals converge to crank up mucin genes. One of the most studied is the cytokine IL-13, a molecule released during allergic inflammation. IL-13 drives goblet cells to produce more mucin, and it does so partly through a receptor pathway called EGFR. Blocking that receptor in laboratory models completely prevented IL-13-induced goblet cell changes. Yet IL-13 and EGFR also appear to act through largely independent gene programs, meaning the body has multiple parallel routes to mucus overproduction, not just one.

Another key player is a transcription factor called FoxA2, which normally acts as a brake on mucin genes. In chronic sinus disease, FoxA2 levels drop while MUC5AC and MUC5B levels rise. The inflammatory molecule IL-6 appears to suppress FoxA2, essentially releasing the brake and allowing mucin production to surge. This matters because it shows that mucus overproduction is not just about turning up the gas; sometimes the body’s natural off switch gets disabled.

Major Conditions That Drive Mucus Overproduction

Infections

The most familiar cause is a respiratory virus. When a virus invades airway cells, the immune response triggers abnormal mucin overproduction and secretion, which can obstruct airways and worsen disease. Respiratory syncytial virus (RSV) is a particularly clear example: in infants, RSV-driven mucus overproduction can cause enough bronchial plugging to require hospitalization. Most viral colds resolve in a week or two, but the mucus can linger because the goblet cells that ramped up during infection take time to return to normal.

Asthma

In asthma, especially the type driven by allergic (Type 2) inflammation, mucus production goes well beyond a runny nose. Type 2 inflammation disrupts glandular stem cells and drives an explosive release of mucin that can form thick plugs in medium and small airways. These mucus plugs are now recognized as a major contributor to airflow limitation in severe asthma, not just a bystander finding on CT scans.

COPD

Mucus hypersecretion is a core feature of COPD and is tied to worse outcomes. It can actually appear before measurable airway obstruction develops, which has led researchers to explore whether early treatment of mucus problems might slow disease progression. In COPD, the combination of goblet cell proliferation, submucosal gland enlargement, and impaired cilia function creates a vicious cycle: too much mucus is produced, it is not moved efficiently, infections take hold more easily, and each infection further damages the clearance system.

Cystic Fibrosis

Cystic fibrosis (CF) produces a fundamentally different kind of mucus problem. A defective ion channel leads to reduced chloride and bicarbonate secretion and increased sodium absorption at airway and gut surfaces. The result is dehydrated, abnormally concentrated mucus that sticks to surfaces instead of flowing. The mucin ratio also shifts, with changes in the balance of MUC5B to MUC5AC that further alter mucus properties like thickness and elasticity. In CF, the issue is less about producing too much mucin and more about the mucus that is produced being too thick, too sticky, and too tightly bound to the airway lining to clear normally.

Environmental and Less Obvious Triggers

Air pollution, and fine particulate matter (PM2.5) in particular, is an increasingly recognized driver of mucus problems. Exposure to PM2.5 activates the same EGFR signaling pathway implicated in asthma-related mucus production, leading to increased MUC5AC output and airway inflammation. PM2.5 also disrupts cilia and the protective barrier of the airway lining, impairing clearance and allowing bacteria to colonize more easily. People living in high-pollution areas may therefore experience chronic mucus overproduction even without a diagnosed lung disease.

Acid reflux is another underappreciated cause. Laryngopharyngeal reflux occurs when stomach contents pass upward beyond the esophagus and irritate the throat and larynx, causing symptoms like hoarseness, chronic cough, a sensation of a lump in the throat, and excess throat mucus. Many people who complain of constant throat clearing and phlegm actually have reflux rather than a respiratory problem, which is why antihistamines and cough syrups do nothing for them.

The nervous system plays a role too. The vagus nerve, which connects the brain to the airways, can trigger a flood of gland mucus through a cholinergic reflex in response to acute threats like inhaling foreign material or very intense exercise. This emergency defense reflex can produce copious mucus volumes almost instantly. Emotional stress and autonomic imbalance can also influence baseline mucus secretion, though the research is less extensive in that area.

The Milk Myth

Few beliefs about mucus are as persistent as the idea that drinking milk increases phlegm production. A controlled study that tracked adults experimentally infected with a cold virus found no statistically significant association between milk and dairy intake and symptoms of mucus production, whether the volunteers were healthy or actively fighting the infection. A later review found that the sensation of increased mucus after drinking milk also occurred with a soy-based drink that had similar texture and mouthfeel, suggesting that the effect is sensory rather than physiological.

That said, the story is not entirely closed. One hypothesis suggests that a breakdown product of a certain type of cow’s milk protein (called beta-casomorphin-7) could theoretically stimulate mucus-producing glands in the gut and possibly the airways, particularly in people who already have airway inflammation. This remains a hypothesis rather than established fact. For the average person with a cold, avoiding milk will not reduce mucus output, but the creamy coating it leaves in the mouth can make existing mucus feel thicker.

Mucolytic and Mucus-Clearing Medications

When mucus becomes a clinical problem, several drug classes can help. N-acetylcysteine (NAC) is one of the oldest and most widely used. It works by breaking the disulfide bonds that cross-link mucin proteins, essentially snipping the internal scaffolding that makes thick mucus so hard to move. In COPD, NAC has an additional rationale: it can reduce the expression of MUC5AC, the mucin that tends to increase during damage and inflammation, and it doubles as an antioxidant.

Hypertonic saline (typically a 3% to 7% salt solution inhaled as a nebulized mist) takes a different approach. It draws water into the airway surface, rehydrating the mucus layer and improving ciliary clearance. This strategy is especially valuable in cystic fibrosis, where mucus dehydration is the central problem. Studies in CF patients have shown improvements in lung function with regular hypertonic saline use, though the gains tend to be smaller than those achieved with the enzyme dornase alfa, which cuts up the DNA strands released by dead white blood cells that make CF mucus particularly viscous.

Biologic Therapies for Mucus Plugging

For people with severe asthma whose airways are plugged with mucus despite standard treatment, biologic medications are a newer frontier. These are injectable drugs that target specific immune molecules upstream of mucus production. A systematic review found that biologic treatments reduced mucus plug scores on CT scans compared with placebo, and the effects were most pronounced in patients with high Type 2 inflammation. Among the drugs studied, tezepelumab, benralizumab, mepolizumab, omalizumab, and reslizumab all showed reductions in mucus plugging, and in several cases these improvements tracked with better lung function, less air trapping, and improved quality of life. Biologics do not thin mucus directly; instead they dial down the inflammatory signaling that drives mucus overproduction in the first place.

Physical Clearance Techniques

Not every mucus problem requires a prescription. Physical airway clearance methods aim to loosen and move mucus mechanically. One well-studied category involves oscillating positive expiratory pressure (OPEP) devices, handheld tools that you breathe out through. They create vibrations and back-pressure in the airways that help shake mucus loose from airway walls and move it toward the mouth. In a pilot study of patients with bronchiectasis and frequent flare-ups, twice-daily use of an OPEP device significantly reduced the number of acute exacerbations and improved symptom scores over the treatment period.

A Cochrane review looking at positive expiratory pressure therapy in cystic fibrosis found that short-term, it performed about as well as other airway clearance methods, though long-term comparisons had mixed results. In practice, most respiratory therapists recommend patients try different clearance methods and stick with whichever one they will actually use consistently, since adherence matters more than the specific device. Other physical approaches include postural drainage (using gravity by lying in specific positions), chest percussion (rhythmic clapping on the chest wall), and active cycle breathing techniques that alternate between deep breaths, breath holds, and forced huffs.

Steam inhalation is the classic home remedy. The thinking is that warm, humid air loosens congested mucus and may help it drain more effectively. Evidence for meaningful clinical benefit from steam alone is limited, but many people find subjective relief, and it is low-risk as long as you avoid scalding yourself with boiling water. Staying well-hydrated is also sensible: dehydration thickens mucus by reducing the water content of airway secretions, and while drinking extra water is not a cure, it helps keep mucus at a consistency the cilia can handle.

Mucus Beyond the Lungs

Mucus overproduction is not exclusively a respiratory problem. The entire gastrointestinal tract is lined with mucus layers that serve a different but equally important purpose: separating the trillions of bacteria in the gut from the tissue beneath. The stomach and colon have a two-layer system with a dense inner layer attached to the epithelium and a looser outer layer. In the small intestine, a single unattached layer normally keeps bacteria at a safe distance. In cystic fibrosis, that small-intestinal layer becomes abnormally attached to the surface, which accounts for the intestinal symptoms of the disease. When the inner mucus barrier of the colon breaks down and bacteria reach the epithelial surface, the immune system reacts with inflammation. This mechanism is thought to play a role in some types of ulcerative colitis, illustrating that mucus dysfunction can cause disease by being too thin or too permeable, not just too thick or too abundant.

How Ancient Mucus Really Is

The mucus defense system is not a mammalian invention. Mucosal surfaces first appeared roughly 560 million years ago in early animals like cnidarians, the group that includes jellyfish and hydra. Researchers have found remarkable similarities between the mucosal immunity of vertebrates and the innate immune defenses of hydra, suggesting a shared evolutionary origin. This deep ancestry helps explain why the mucus response is so robust and so difficult to turn off cleanly once triggered: half a billion years of evolution have tuned mucus production to err on the side of too much rather than too little. From the body’s perspective, a few days of annoying congestion is a small price compared with letting a pathogen through.